Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia

NCT04742101 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: S65487 and azacitidine

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]